Literature DB >> 6210779

Measurements of neuromuscular tone and strength in Down's syndrome children.

A F Morris, S E Vaughan, P Vaccaro.   

Abstract

Twenty-eight Down's syndrome children and 22 normal children were evaluated for patellar tendon reflex, muscle tone and grip strength. All of this subjects were between the ages of 4 and 17 years. It was the purpose of this study to determine the differences between Down's syndrome and normal children. The standard patellar reflex test was used for one measure of muscle tone, and a locally devised muscle palpation test for the second measure of muscle tone. Finally, grip strength was employed as our measure of muscle strength. Results indicated that Down's syndrome children had a less brisk and more irregular patellar reflex response than normal controls. Furthermore, overall muscular tone was less in these Down's syndrome subjects and finally, muscular grip strength was inferior in Down's syndrome children when compared to normal children. Implications for increased physical education and physical activity are noted for this special population.

Entities:  

Mesh:

Year:  1982        PMID: 6210779     DOI: 10.1111/j.1365-2788.1982.tb00127.x

Source DB:  PubMed          Journal:  J Ment Defic Res        ISSN: 0022-264X


  21 in total

1.  Stiffness and postural stability in adults with Down syndrome.

Authors:  A Webber; N Virji-Babul; R Edwards; M Lesperance
Journal:  Exp Brain Res       Date:  2004-02-05       Impact factor: 1.972

2.  Functional assessments of the knee joint biomechanics by using pendulum test in adults with Down syndrome.

Authors:  Antonino Casabona; Maria Stella Valle; Mariangela Pisasale; Maria Rosita Pantò; Matteo Cioni
Journal:  J Appl Physiol (1985)       Date:  2012-09-20

3.  Motor strategies and motor programs during an arm tapping task in adults with Down Syndrome.

Authors:  Sara Laura Vimercati; Manuela Galli; Chiara Rigoldi; Andrea Ancillao; Giorgio Albertini
Journal:  Exp Brain Res       Date:  2012-12-29       Impact factor: 1.972

4.  A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions.

Authors:  Tao Yu; Zhongyou Li; Zhengping Jia; Steven J Clapcote; Chunhong Liu; Shaomin Li; Suhail Asrar; Annie Pao; Rongqing Chen; Ni Fan; Sandra Carattini-Rivera; Allison R Bechard; Shoshana Spring; R Mark Henkelman; George Stoica; Sei-Ichi Matsui; Norma J Nowak; John C Roder; Chu Chen; Allan Bradley; Y Eugene Yu
Journal:  Hum Mol Genet       Date:  2010-05-04       Impact factor: 6.150

5.  Praxis skills in young children with Down syndrome, other developmental disabilities, and typically developing children.

Authors:  Deborah J Fidler; Susan L Hepburn; Galit Mankin; Sally J Rogers
Journal:  Am J Occup Ther       Date:  2005 Mar-Apr

6.  Stride-level analysis of mouse open field behavior using deep-learning-based pose estimation.

Authors:  Keith Sheppard; Justin Gardin; Gautam S Sabnis; Asaf Peer; Megan Darrell; Sean Deats; Brian Geuther; Cathleen M Lutz; Vivek Kumar
Journal:  Cell Rep       Date:  2022-01-11       Impact factor: 9.423

Review 7.  Endocrine and musculoskeletal abnormalities in patients with Down syndrome.

Authors:  Yousra Hawli; Mona Nasrallah; Ghada El-Hajj Fuleihan
Journal:  Nat Rev Endocrinol       Date:  2009-06       Impact factor: 43.330

8.  Down Syndrome Related Muscle Hypotonia: Association with COL6A3 Functional SNP rs2270669.

Authors:  Arpita Dey; Krishnendu Bhowmik; Arpita Chatterjee; Pit Baran Chakrabarty; Swagata Sinha; Kanchan Mukhopadhyay
Journal:  Front Genet       Date:  2013-04-22       Impact factor: 4.599

Review 9.  Down syndrome: searching for the genetic culprits.

Authors:  Eva Lana-Elola; Sheona D Watson-Scales; Elizabeth M C Fisher; Victor L J Tybulewicz
Journal:  Dis Model Mech       Date:  2011-09       Impact factor: 5.758

10.  Dyrk1A is dynamically expressed on subsets of motor neurons and in the neuromuscular junction: possible role in Down syndrome.

Authors:  Gloria Arque; Anna Casanovas; Mara Dierssen
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.